Concepedia

Lin Shui

LS

Statistics

Publications

6

Citations

104

H-Index

6

Active since

2019

Affiliations

Sichuan University(Current)

West China Hospital of Sichuan University

The Affiliated Yongchuan Hospital of Chongqing Medical University

Chongqing Medical University

State Key Laboratory of Biotherapy

Lin Shui is an author at Sichuan University specializing in vascular biology, tumor microenvironment, and tumor biology.

ORCID

Top concepts

Publications per year

2019–2021

6

Publications

6

HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway

Hongqiang Wang, Xuchun Yang, Yan Guo et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 37 citations · Full text

The germline/somatic DNA damage repair gene mutations modulate the therapeutic response in Chinese patients with advanced pancreatic ductal adenocarcinoma

Lin Shui, Xiaofen Li, Yang Peng et al. · Journal of Translational Medicine · 2021 · 17 citations · Full text

Study protocol for an open-label, single-arm, phase Ib/II study of combination of toripalimab, nab-paclitaxel, and gemcitabine as the first-line treatment for patients with unresectable pancreatic ductal adenocarcinoma

Lin Shui, Ke Cheng, Xiaofen Li et al. · BMC Cancer · 2020 · 16 citations · Full text

Durable Response and Good Tolerance to the Triple Combination of Toripalimab, Gemcitabine, and Nab-Paclitaxel in a Patient With Metastatic Pancreatic Ductal Adenocarcinoma

Lin Shui, Ke Cheng, Xiaofen Li et al. · Frontiers in Immunology · 2020 · 13 citations · Full text

Bacterial particles retard tumor growth as a novel vascular disrupting agent

Fengzhu Guo, Gaili Ji, Qiqi Li et al. · Biomedicine & Pharmacotherapy · 2019 · 11 citations · Full text

, , +16

1–5 of 6